Sucralfate 1gm Suspension (per 10ml) — Oral Liquids
WHO-GMP Certified Commercial Pack · Product Code: AKP-034

Sucralfate 1gm Suspension (per 10ml)

Formulation Overview: Mucosal protective aluminium sucrose sulfate suspension forming a viscous, acid-resistant barrier over ulcer craters to accelerate epithelial healing without systemic absorption. Formulated with Sucralfate USP / IP 1000 mg (per 10 ml) (1 g / 10 ml) in Oral Cytoprotective Suspension dosage form under Gastroenterology & PPIs, manufactured to IP / BP / USP Compendial standards and supplied in 200 ml Amber PET Bottle with Graduated Measuring Cap with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
Item Code (SKU)AKP-034
Therapeutic SectorGastroenterology & PPIs
Dosage FormOral Cytoprotective Suspension
Active IngredientSucralfate USP / IP 1000 mg (per 10 ml)
Strength / Purity1 g / 10 ml
Clinical IndicationActive duodenal ulcer, gastric ulcer, gastroesophageal mucosal erosion, and stress ulcer prophylaxis
Specification StandardIP / BP / USP Compendial
Packaging Format200 ml Amber PET Bottle with Graduated Measuring Cap
Shelf Life24–36 Months
Storage ConditionsStore below 25°C; shake well before use; do not freeze
Minimum Order Quantity1000 Packs
Regulatory / Analytical DocsFull eCTD / ACTD Modules 1–5 + Zone IVb Stability Available
African & Global NRA ReadinessNAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA
Stock AvailabilityIn Stock · Immediate Commercial Dispatch
Supply StatusCommercial Export Ready

Related Oral Liquids & Gastroenterology & PPIs